Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE rejects Eisai’s Halaven in earlier setting for metastatic breast cancer

February 22, 2018
Sales and Marketing Brest cancer, Cancer, Eisai, Halaven, NICE, pharma

NICE has published its decision not to recommend Eisai’s Halaven (eribulin) in the treatment of locally advanced or metastatic breast …

News
flumist

CDC U-turns previous decision on AZ’s flu vaccine

February 22, 2018
Sales and Marketing AstraZeneca, Vaccine, biotech, drugs, flu, influenza, pharma, pharmaceutical

The US Centers for Disease Control and Prevention (CDC) has now recommended AstraZeneca’s FluMist as an option for doctors for …

News
regeneron

Reports increasing of worrying side-effects with Regeneron’s Eylea

February 22, 2018
Medical Communications, Research and Development, Sales and Marketing Eylea, FDA, Regeneron, pharma

Reports are emerging which detail some pretty alarming side-effects in patients receiving Regeneron’s blockbuster eye drug Eylea: once injected into …

News
greek_parliament

Greek parliament moves to investigate 10 politicians

February 22, 2018
Medical Communications, Sales and Marketing Greece, Greek Parliament, Novartis, biotech, drugs, pharma, pharmaceutical

After a 20-hour debate, Greek parliament has voted in favour of investigating 10 politicians named as part of an investigation …

News
merckincweb

MSD poised to acquire viral immuno-oncology firm Viralytics for $394m

February 21, 2018
Research and Development, Sales and Marketing Cancer, MSD, Merck, Viralytics, acquisition, keytruda, oncology, pharma

MSD, known as Merck in the US, has announced it is to buy Australian viral immuno-oncology firm Viralytics for $394 …

News
astrazeneca_logo_building

AZ licenses kidney drug from Ionis for $330m

February 21, 2018
Research and Development, Sales and Marketing AstraZeneca, Ionis, Isis, biotech, drugs, kidney, pharma, pharmaceutical

AstraZeneca continues to build on its relationship with San Diego-based Ionis Pharmaceuticals, this time by agreeing a licensing deal for …

News
peanuts_nuts_snack_nutrition_healthy_nibble_decoration_close-842313

Aimmune’s peanut allergy candidate hits main endpoint at Phase 3

February 21, 2018
Research and Development Aimmune, peanut, peanut allergy, pharma

US biopharmaceutical firm Aimmune has revealed that its peanut allergy candidate AR101 hit its primary endpoint in the largest trial …

News
abbviehqe_004_low

AbbVie turns to tau for Alzheimer’s in $1.1bn deal

February 21, 2018
Research and Development, Sales and Marketing AbbVie, Alzheimer's, Voyager, biotech, drugs, pharma, pharmaceutical

Sailing against the prevailing winds in the Alzheimer’s disease space, AbbVie has launched a deal worth a potential $1.1 billion …

News
heart_rope

Google develops AI to predict cardiovascular risk

February 21, 2018
Research and Development AI, Verily Life Sciences, biotech, cardiovascular, drugs, google, pharma, pharmaceutical

Google and Verily Life Sciences, a subsidiary within Alphabet, focused on developing health-tech, have revealed the fruits of a combined …

News

NICE recommends thyroid cancer drug trio for NHS use

February 20, 2018
Manufacturing and Production, Sales and Marketing Bayer, Cancer, Cometriq, Eisai, Lenvima, NICE, Nexavar, ipsen, pharma, thyroid cancer

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use …

News
business_generic

Shire, Microsoft and EURORDIS form rare disease alliance

February 20, 2018
Manufacturing and Production, Research and Development Microsoft, Shire, eurordis, pharma, rare disease

Rare disease specialist pharma firm Shire, rare disease patient alliance EURORDIS and tech giant Microsoft have announced they have formed …

News
flu_virus

Low flu vaccine efficacy may be due to previous immune history, study finds

February 20, 2018
Manufacturing and Production, Research and Development H3N2, Vaccine, flu, flue vaccine, influenza, pharma

The sometimes poor efficacy of influenza vaccines may be due to poor immune response and a patient’s wider immune history, …

News
shutterstock_138095450

Japan’s Oncolys invests £3m in adenovirus firm Unleash Immuno Oncolytics

February 20, 2018
Manufacturing and Production, Research and Development, Sales and Marketing Oncolys, Unleash Immuno Oncolytics, pharma

Unleash Immuno Oncolytics, a US firm focusing on the development of viral biologics in the treatment of cancer, has attracted …

News
lilly_entrance_web

Lilly dumps Hanmi’s rheumatoid arthritis med

February 20, 2018
Manufacturing and Production, Sales and Marketing Eli Lilly, arthritis, hanmi, pharma

Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, …

News
img_9530_resized

Patient experience: Living with multiple myeloma

February 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, mutiple myeloma, patient experience, pharma

Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support …

Feature
fda_building

Apricus shares sink after failed erectile dysfunction application

February 19, 2018
Sales and Marketing Apricus, biotech, drugs, pharma, pharmaceutical

Apricus Biosciences had a lot riding on its application to the FDA for its erectile dysfunction cream, Vitaros, with the …

News
janssen_latest_logo_on_sign

Janssen’s Tremfya shows long-term efficacy in moderate to severe plaque psoriasis

February 19, 2018
Research and Development, Sales and Marketing Janssen, Tremfyam guselkumab, pharma, plaque psoriasis, psoriasis

Janssen has unveiled new Phase 3 trial data for its IL-23 inhibitor Tremfya (guselkumab), demonstrating that the drug was able …

News
celgene_1_02

Celgene reveals strong P3 Otezla data in rare inflammatory condition

February 19, 2018
Research and Development, Sales and Marketing Behçet's disease, Celgene, apremilast, otezla, pharma

Celgene has lifted the curtain on strong new Phase 3 data for its phosphodiesterase 4 (PDE4) inhibitor Otezla (apremilast) in …

News
gavel

Long-running, $2.5bn lawsuit swings in Gilead’s favour

February 19, 2018
Sales and Marketing Gilead, MSD, biotech, drugs, harvoni, pharma, pharmaceutical, sovaldi

The fate of pharma company’s profits and losses largely rests on product approvals and the sales team behind them but, …

News
astrazeneca_sign_sky

AZ’s Imfinzi seals blockbuster lung cancer market with FDA nod

February 19, 2018
Sales and Marketing AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical

AstraZeneca’s immunotherapy, Imfinzi, arrived to the industry as a failure – there were big hopes resting on the company’s Mystic …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026